TrialCompass TCL
Back to results
RecruitingPriority 4 · Lower priorityNCT07160023

Local Registry of Primary Cutaneous T-cell Lymphomas

ClinicalTrials.gov

Plain-language summary

This trial is studying a new treatment for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join (key eligibility)

  • Age 6 Years or older
  • See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Drugs / treatments
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

Local Registry of Primary Cutaneous T-cell Lymphomas

NCT07160023

Phase: | Status: Recruiting | Priority: Lower

Plain-language summary

This trial is studying a new treatment for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join

  • Age 6 Years or older
  • See full trial listing for complete eligibility

What's being tested

Drugs / treatments:

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 600 patients

Primary endpoint: prevalence of cutaneous T-cell lymphoma (CTCL) variants

Ages: 6 Years to —

Start date: 2023-10-12 | Est. completion: 2033-10-12

Locations

0 US sites · 1 total

Contact

Valeria Brazzelli, MD | v.brazzelli@smatteo.pv.it | 0382503794

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia (OTHER)

Tags

CTCL · any

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT07160023

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.